Vocus to invest $500M in Sydney-Melbourne fibre route
Communications infrastructure provider Vocus will invest $500 million in a new Sydney-to-Melbourne long-haul fibre route.
Communications infrastructure provider Vocus will invest $500 million in a new Sydney-to-Melbourne long-haul fibre route.
Firefly Aerospace (NASDAQ:FLY) announced it received a $144 million NASA CLPS contract to deliver an accelerated Blue Ghost lunar lander mission targeted for 2028.
Brand Engagement Network (NASDAQ:BNAI) completed its acquisition of Cataneo on June 30, 2026, adding a profitable enterprise software business with recurring revenue.
President Donald Trump suspended certain duties on phosphate fertilizer imported from Morocco for up to eight months to support U.S. farm supply before the next planting season.
Abivax stock climbed more than 30% after the French biotech released additional data from its late-stage trial of obefazimod, showing that cancer cases in the study were consistent with background rates expected in that patient population.
Toyota (NYSE:TM) and Joby Aviation (NYSE:JOBY) launched the initial phase of a strategic manufacturing alliance, creating a joint venture to advance all-electric air taxi production.
PetMed Express (NASDAQ:PETS) confirmed receipt of an unsolicited, non-binding and conditional proposal from SilverCape Investments to acquire all outstanding shares for $3.00 per share in cash.
ADC Therapeutics SA (NYSE:ADCT) said it has completed enrollment in the LOTIS-7 Phase 1b clinical trial evaluating ZYNLONTA in combination with glofitamab for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
The combined market value of the Magnificent Seven — Microsoft (NASDAQ:MSFT), Nvidia (NASDAQ:NVDA), Alphabet (NASDAQ:GOOGL), Apple (NASDAQ:AAPL), Meta Platforms (NASDAQ:META), Tesla (NASDAQ:TSLA), and Amazon.com (NASDAQ:AMZN) — fell about $2.3 trillion in June, according to CNBC.
ADC Therapeutics (NYSE:ADCT) said it has completed enrollment in the LOTIS-7 Phase 1b clinical trial evaluating ZYNLONTA in combination with glofitamab for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
GARANTA JÁ SEU GRAFA EDGE
Sign up free to unlock this feature
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas